Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Lung Neoplasms 2Hot Flashes 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Peripheral Nervous System Diseases 1Febrile Neutropenia 1Cross Infection 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Etoposide 3Drug Therapy 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2cemiplimab 2Vincristine 2Temozolomide 2Platinum 2Paclitaxel 2Injections 2Immunotherapy, Adoptive 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Docetaxel 2Carboplatin 2Capecitabine 2Bevacizumab 2venetoclax 1relmacabtagene autoleucel 1pomalidomide 1pirtobrutinib 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × Acupuncture Therapy × Clear all
NCT07098949 2025-08-01

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Guangzhou University of Traditional Chinese Medicine

Phase NA Not yet recruiting
346 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡